financetom
Business
financetom
/
Business
/
Guidewire Software Might Set New Long-Term Targets Showing Sustained Growth Momentum, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Guidewire Software Might Set New Long-Term Targets Showing Sustained Growth Momentum, Oppenheimer Says
Oct 4, 2024 6:58 PM

11:56 AM EDT, 10/04/2024 (MT Newswires) -- Guidewire Software ( GWRE ) might present new long-term financial targets during its Oct. 10 investor day, including a $2 billion annual recurring revenue in fiscal year 2030, Oppenheimer said Friday in a note.

The firm also projects fiscal 2030 gross margin at mid-70% and operating cash flow margin at mid-30% for the technology company.

Guidewire Software ( GWRE ) is expected to formally set fiscal 2027 and 2028 targets of $1.5 billion ARR and OCF margin of 29% to 32% on its investor day, Oppenheimer said.

"We expect any forward growth rate commentary to remain in the mid-teens range, supported by Tier-1 adoption, cloud migrations, and price optimization," the firm said. "We still see headroom to estimates with cloud conversions, T-1 adoption, and [direct written premium] true-ups sustaining growth momentum."

Oppenheimer maintained its outperform rating on the stock, while raising its price target to $200 from $185 "to reflect elevated confidence in GWRE's long-term trajectory."

Price: 183.86, Change: +1.55, Percent Change: +0.85

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Marinus Pharmaceuticals Shares Plunge as Phase 3 Trial of Ganaxolone Fails to Meet Goal; Plans to Cut Costs, Explore Alternatives
Marinus Pharmaceuticals Shares Plunge as Phase 3 Trial of Ganaxolone Fails to Meet Goal; Plans to Cut Costs, Explore Alternatives
Oct 25, 2024
03:08 PM EDT, 10/24/2024 (MT Newswires) -- Marinus Pharmaceuticals ( MRNS ) shares plunged nearly 82% in recent Thursday trading after the company said its phase 3 trial of oral ganaxolone failed to meet its main goal and announced plans to reduce costs and explore alternatives for the business. Marinus was studying the drug as a treatment for seizures associated...
Deckers Outdoors raises annual sales forecast on strong demand for Hoka shoes
Deckers Outdoors raises annual sales forecast on strong demand for Hoka shoes
Oct 25, 2024
Oct 24 (Reuters) - Deckers Outdoor ( DECK ) beat Wall Street estimates for second-quarter results and raised its annual sales forecast on Thursday, as its brands such as UGG boots and Hoka running shoes continue to resonate with customers. The company's shares were up 8.5% at $164.80 after the bell, set to add to the about 35% gain so...
--L3Harris Technologies Lifts Full-Year 2024 Adjusted Segment Operating Margin Guidance to 15.5%
--L3Harris Technologies Lifts Full-Year 2024 Adjusted Segment Operating Margin Guidance to 15.5%
Oct 25, 2024
04:44 PM EDT, 10/24/2024 (MT Newswires) -- Price: 254.00, Change: +9.83, Percent Change: +4.03 ...
US court blocks Tapestry's $8.5 billion acquisition of rival Capri
US court blocks Tapestry's $8.5 billion acquisition of rival Capri
Oct 25, 2024
NEW YORK, Oct 24 (Reuters) - A U.S. judge blocked the pending $8.5 billion merger of U.S. handbag and accessories maker Tapestry and Capri on Thursday, a victory for the U.S. Federal Trade Commission in an industry where merger challenges are rare. The FTC argued at an eight-day trial in New York that the merger would eliminate fierce head-to-head competition...
Copyright 2023-2025 - www.financetom.com All Rights Reserved